Jing Xu

Recent Developments in Pharmacological Effect, Mechanism and Application Prospect of Diazeniumdiolates

Bin Li, Jing Xu, Chen Li, 2020, Frontiers in Pharmacology.

Fibroblast growth factor 2 inhibits bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2.

J. Xu, Jinyong Luo, Jian Wang, 2013, The international journal of biochemistry & cell biology.

Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.

Q. Shi, J. Xu, Tongchuan He, 2013, Oncology reports.

Activation of JNKs is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells

J. Xu, M. Tang, Yan-fang Zhao, 2013, BMB reports.